Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Methylphenidate Hydrochloride for Sustained-release Suspension

Approval Number

国药准字HJ20230151

CompanyNextWave Pharmaceuticals, Inc.

Registration Date

December 29, 2023

Drug Information

Generic Name

盐酸哌甲酯缓释干混悬剂

Dosage Form

口服混悬剂

Strength

600mg

Drug Type

化学药品

Registration Date

December 29, 2023

Expiry Date

December 28, 2028

Company Information

Applicant Company

Company NameNextWave Pharmaceuticals, Inc.

Company Address

2033 Us Highway 130, Monmouth Junction, NJ 08852 United States of America

Manufacturing Company

Company NameTRIS PHARMA, INC.

Company Address

2033 US 130, Monmouth Junction, NJ 08852 United States of America

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸哌甲酯缓释干混悬剂 - NMPA 批准文号 | MedPath